QA: Mylan INC in us_pharma/2010

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000069499_2011_Mylan_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000069499, Mylan INC

  xvar xval
0 AssetsCurrent 3,559,443,000
1 IntangibleAssetsNetIncludingGoodwill 6,100,484,000
2 PropertyPlantAndEquipmentNet 1,209,342,000
3 remainder_Assets 667,535,000
4 LiabilitiesCurrent 1,809,612,000
5 LiabilitiesNoncurrent 5,633,697,000
6 remainder_Liabilities 478,094,000
7 CostOfGoodsAndServicesSold 3,233,125,000
8 SellingGeneralAndAdministrativeExpense 1,086,609,000
9 ResearchAndDevelopmentExpense 282,146,000
10 remainder_Expenses 468,922,000
11 remainder_Revenues 5,450,522,000
12 remainder_NetIncome -34,178,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 11,536,804,000
1 Liabilities 7,921,403,000
2 Expenses 5,070,802,000
3 Revenues 5,450,522,000
4 StockholdersEquity 3,615,401,000
5 NetIncome 345,542,000
6 ComprehensiveNetIncome 345,542,000
7 BaseVar 15,006,854,500
8 EconomicCapitalRatiobeforeLimitedLiability 0.846
9 EconomicCapitalRatio 2.18

Edgar->Model Mapping

Feature Distribution